Collaborative Molecular Epidemiology Study of Metabolic Dysregulation, DNA Methylation, and Breast Cancer Risk Among Nigerian Women: MEND Study Objectives and Design
MetadataShow full item record
PublisherAMER SOC CLINICAL ONCOLOGY
CitationAkinyemiju, T., Salako, O., Daramola, A., Alatise, O., Adeniyi, A., Ogun, G., ... & Adisa, A. (2019). Collaborative Molecular Epidemiology Study of Metabolic Dysregulation, DNA Methylation, and Breast Cancer Risk Among Nigerian Women: MEND Study Objectives and Design. Journal of global oncology, 5, 1-9.
JournalJOURNAL OF GLOBAL ONCOLOGY
RightsCopyright © 2019 American Society of Clinical Oncology. All rights reserved. Licensed under the Creative Commons Attribution 4.0 License.
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at firstname.lastname@example.org.
AbstractPURPOSE To elucidate the role of metabolic dysregulation and associated DNA methylation changes on breast cancer risk and aggressive subtypes among Nigerian women. We describe the design and methods of a collaborative molecular epidemiology study of breast cancer in Nigerian hospitals. METHODS The Mechanisms for Novel and Established Risk Factors for Breast Cancer in Women of Nigerian Descent (MEND) study was designed as a matched case-control study of 350 patients, age 18 to 75 years, with newly diagnosed, treatment-naive breast cancer and 350 age-matched healthy controls from surrounding geographic areas. Patients with breast cancer seen for initial diagnosis at four large tertiary hospitals in southwest Nigeria and one affiliated private hospital were recruited. Healthy female controls were selected from a cohort of 4,000 healthy women recruited as part of the Human Heredity and Health (H3) in Africa Chronic Kidney Disease Case-Control Study in Nigeria. Tumor and adjacent normal tissue, and blood and saliva samples were collected for molecular and epigenetic assays. RESULTS Although recruitment is ongoing, a total of 416 patients have been recruited to date, with tumor and blood samples obtained from at least 310 patients. Data on age-matched (6 months) controls have also been obtained and harmonized. Lipid assays for 350 pathologically verified cases and 350 age-matched controls is underway, and pathologic characterization of tumors (including immunohistochemistry for subtyping) is ongoing. Data on DNA methylation for tumors and adjacent normal tissue are expected by the end of the study period. CONCLUSION The MEND study will provide a unique, high-quality source of data to evaluate the contribution of metabolic dysregulation such as obesity, diabetes, hypertension, and metabolic syndrome to the biology of breast cancer among Nigerian women and foster collaborative studies relevant for women of African descent globally. J Global Oncol. (C) 2019 by American Society of Clinical Oncology.
NoteOpen access journal
VersionFinal published version
SponsorsNational Institutes of Health, National Cancer Institute, Fogarty International Center [K01TW010271]
- A collaborative study of the etiology of breast cancer subtypes in African American women: the AMBER consortium.
- Authors: Palmer JR, Ambrosone CB, Olshan AF
- Issue date: 2014 Mar
- Case-control study of risk factors for breast cancer in Nigerian women.
- Authors: Okobia M, Bunker C, Zmuda J, Kammerer C, Vogel V, Uche E, Anyanwu S, Ezeome E, Ferrell R, Kuller L
- Issue date: 2006 Nov 1
- Normal breast tissue DNA methylation differences at regulatory elements are associated with the cancer risk factor age.
- Authors: Johnson KC, Houseman EA, King JE, Christensen BC
- Issue date: 2017 Jul 10
- Anthropometry and breast cancer risk in Nigerian women.
- Authors: Okobia MN, Bunker CH, Zmuda JM, Osime U, Ezeome ER, Anyanwu SN, Uche EE, Ojukwu J, Kuller LH
- Issue date: 2006 Sep-Oct
- Methyl-group dietary intake and risk of breast cancer among African-American women: a case-control study by methylation status of the estrogen receptor alpha genes.
- Authors: Zhu K, Davidson NE, Hunter S, Yang X, Payne-Wilks K, Roland CL, Phillips D, Bentley C, Dai M, Williams SM
- Issue date: 2003 Nov